Affordable Access

Melatonin Regulates Angiogenic Factors Under Hypoxia in Breast Cancer Cell Lines

  • Jardim-Perassi, Bruna Victorasso
  • Lourenco, Mateus Repoles
  • Doho, Gabriel Mandarini
  • Grigolo, Ingrid Helen
  • Gelaleti, Gabriela Bottaro
  • Ferreira, Livia Carvalho
  • Borin, Thaiz Ferraz
  • Moschetta, Marina Gobbe
  • Pires de Campos Zuccari, Debora Aparecid...
Publication Date
Jan 01, 2016
Repositório Institucional UNESP
External links


Angiogenesis is the process of new blood vessel formation, regulated by a number of pro-and anti-angiogenic factors and usually begins in response to hypoxia. Exogenous administration of melatonin has shown numerous anti-tumor effects and appears to inhibit tumor angiogenesis. However, many factors involved in the anti-angiogenic effect of melatonin are still under investigation. Here, we evaluate the effects of melatonin on cell viability and expression of angiogenic factors in MCF-7 and MDA-MB-231 breast cancer cells under hypoxic conditions. Cell viability was investigated by MTT and gene and protein expression of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF-A) were verified by qPCR and immunocytochemistry after melatonin treatment (1 mM) under hypoxic conditions. Additionally, a protein array with 20 different cytokines/factors was performed on tumor cell lysates. The results showed that 1 mM of melatonin reduced the viability of MCF-7 and MDA-MB-231 cells (p < .05). This treatment also decreased both gene and protein expression of HIF-1a and VEGF-A under hypoxic conditions (p < .05). Among the proteins evaluated by protein array, melatonin treatment during hypoxia reduced VEGF-C, VEGFR receptors (VEGFR2 and VEGFR3), matrix metalloproteinase 9 (MMP9) and Angiogenin in MCF-7 cells. In MDA-MB-231 cells, a significant decrease was observed in VEGFR2, epidermal growth factor receptor (EGFR) and Angiogenin (p < .05). Taken together, these results showed that melatonin acts in the regulation of angiogenic factors in breast tumor cells and suggests an anti-angiogenic activity, particularly under hypoxic conditions.

Report this publication


Seen <100 times